BCL-XL; MS X-50UG

Code: MAB3121 D2-231

Application

Flow cytometry:
Immunoprecipitation (Cheng, 1996; Gottschalk, 1996)

Immunohisto...


read more

Your Price
€529.00 EACH
€650.67 inc. VAT

Application

Flow cytometry:
Immunoprecipitation (Cheng, 1996; Gottschalk, 1996)

Immunohistochemistry (Foreman, 1996; Wrone-Smith, 1995)

Western blotting: ( 0.5 µg/mL)

Optimal working dilutions must be determined by end user.

Detect Bcl-XL & BclXs using this Anti-Bcl-XL & BclXs Antibody, clone 7B2.5 validated for use in FC, IP, WB, IH.

Research CategoryApoptosis & Cancer

Research Sub CategoryBCL2 & Inhibition

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Immunogen

Recombinant Bcl-XS.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Physical form

Purified immunoglobulin - Ig fraction. Liquid in borate buffer saline, pH 8.2.

Format: Purified

Specificity

Apoptosis, or programmed cell death, is a well-documented phenomenon in many cellular systems (Cohen, 1991). It plays a key role in tissue and organ development, as well as in adult tissues during cell turnover. Apoptosis can be induced by a variety of internal and external stimuli including growth factor deprivation, cytokine treatment, antigen-receptor engagement, cell-cell interactions, irradiation and glucocorticoid treatment (Cohen & Duke, 1992). Bcl-2 and one of its homologues, Bcl-XL, protect cells from apoptosis (Nunez & Clarke, 1994; Cory, 1995), while other homologues of Bcl-2 such as Bax, Bad and Bak have been shown to enhance apoptosis (Oltvai, 1993; Farrow, 1995; Chittenden, 1995; Kiefer, 1995). Bcl-XL has been shown to block apoptosis which is induced by a variety of stimuli and, under certain conditions, offers greater protection against apoptosis than Bcl-2 (Boise, 1993; Gottschalk, 1994; Gonzalez-Garcia, 1995; Dole, 1995; Shimizu, 1995). In contrast, Bad and Bax inhibit the protective functions of Bcl-XL and Bcl-2, respectively. Although heterodimerization between Bcl-XL, Bad and Bcl-2/Bax was originally thought to be essential for the differential anti-apoptotic activity of Bcl-XL and Bcl-2 (Oltvai, 1993; Yin, 1994); other results suggest that the formation of heterodimers may not be necessary for this death-repressing activity Cheng, 1996; Gottschalk, 1996). This antibody recognizes Human Bcl-XL (Mr 29 kDa) and Bcl-Xs (Mr 21 kDa).

Storage and Stability

Store at 2-8°C for up to 12 months.

antibody formpurified immunoglobulin
antibody product typeprimary antibodies
biological sourcemouse
clone7B2.5, monoclonal
Gene Informationhuman ... BCL2L1(598)
isotypeIgG3
manufacturer/tradenameChemicon®
NCBI accession no.NM_001191.2, NM_138578.1
Quality Level100
shipped inwet ice
species reactivityhuman
technique(s)western blot: suitable, flow cytometry: suitable, immunoprecipitation (IP): suitable, immunohistochemistry: suitable
UniProt accession no.Q07817
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN


GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.